A new surgical procedure to permanently change eye color is gaining traction in the U.S. But many ophthalmologists fear ...

Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for cancer, announced a new partnership with the Experimental Drug Development ...

A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, ...

This development comes at a time when pharmaceutical firms are discontinuing discovery efforts in next-generation COVID-19 ...

An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...

Neurodegenerative disorders have increasing incidence with limited treatment options. Approaches to target neuroinflammation in various neurodegenerative disorders, such as Alzheimer’s disease (AD), ...

Biogen BIIB announced that the FDA has granted fast track designation to its investigational Alzheimer's disease (AD) drug, BIIB080. How Does the Fast Track Tag Benefit BIIB’s Drug Development? Fast ...

Roche Holding said it will initiate a late-stage trial for its Alzheimer's drug candidate trontinemab later this year after its mid-stage study showed positive results.

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

BeiGene is ending development of its experimental lung-cancer treatment ociperlimab following the failure of a late-stage study. BeiGene on Thursday said it is stopping a Phase 3 trial of ociperlimab ...

Today, there is no approved pill that can reliably treat severe obesity on its own. Obesity affects over 40% of adults in the United States and is linked to serious health issues like heart disease, ...